Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study (Q43687289)
Jump to navigation
Jump to search
scientific article published on 23 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study |
scientific article published on 23 October 2012 |
Statements
1 reference
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study (English)
1 reference
Eiichi Ogawa
1 reference
Norihiro Furusyo
1 reference
Eiji Kajiwara
1 reference
Kazuhiro Takahashi
1 reference
Hideyuki Nomura
1 reference
Toshihiro Maruyama
1 reference
Yuichi Tanabe
1 reference
Takeaki Satoh
1 reference
Makoto Nakamuta
1 reference
Kazuhiro Kotoh
1 reference
Koichi Azuma
1 reference
Kazufumi Dohmen
1 reference
Shinji Shimoda
1 reference
Jun Hayashi
1 reference
Kyushu University Liver Disease Study (KULDS) Group
1 reference
23 October 2012
1 reference
1 reference
Identifiers
1 reference